NEW YORK (GenomeWeb) – NeoGenomics reported Wednesday morning that fourth quarter revenues grew 12 percent, fueled by strong growth in clinical genetic testing volume and pharmaceutical services.

For the three months ended Dec. 31, 2017, NeoGenomics reported revenues of $67.8 million compared to $60.5 million in the same quarter last year, beating the average analyst estimate of $66.3 million.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.